GlassScriptPhysician profile
Eunbi Park
NPI 1588492235
$963.87
in general payments reported to CMS, 2019-2025
14 companies · $964 in 2025
The $964 reported for 2025 was more than what 84% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $176.25 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Lilly USA, LLC | $140.82 | 2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2025 | Jardiance |
| Xeris Pharmaceuticals, INC. | $118.54 | 2025 | Recorlev |
| Novo Nordisk INC | $89.58 | 2025 | Ozempic, Rybelsus |
| Corcept Therapeutics | $71.91 | 2025 | Korlym |
| Insulet Corporation | $56.44 | 2025 | Omnipod |
| Madrigal Pharmaceuticals | $48.37 | 2025 | Rezdiffra |
| Sanofi-Aventis U.S. LLC | $44.99 | 2025 | |
| Ucb, INC. | $22.49 | 2025 | Bimzelx |
| Ibsa Pharma INC. | $18.65 | 2025 | Tirosint, Flector, Licart |
| Leo Pharma INC. | $18.21 | 2025 | Anzupgo |
| Endo USA, INC. | $16.68 | 2025 | Aveed |
| Mannkind Corporation | $15.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eunbi Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.